Buckingham Strategic Wealth’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Buckingham Strategic Wealth’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-35,600	Closed	-$100K	–	315
2017 Q2	$100K	Hold	35,600	–	–	0.02%	291
2017 Q1	$68K	Hold	35,600	–	–	0.02%	256
2016 Q4	$62K	Hold	35,600	–	–	0.02%	229
2016 Q3	$96K	Hold	35,600	–	–	0.03%	222
2016 Q2	$84K	Hold	35,600	–	–	0.03%	239
2016 Q1	$115K	Hold	35,600	–	–	0.04%	227
2015 Q4	$171K	Hold	35,600	–	–	0.06%	195
2015 Q3	$198K	Hold	35,600	–	–	0.07%	195
2015 Q2	$283K	Buy	+35,600	New	+$306K	0.09%	165

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Buckingham Strategic Wealth's BDSI Position: Q3 2017 in Review

Buckingham Strategic Wealth sold out of BioDelivery Sciences International, Inc. (BDSI) in Q3 2017, closing a stake of 35,600 shares — an estimated $100K sold.

Buckingham Strategic Wealth first reported a position in BDSI in Q2 2015 and held it in 9 quarters. The position peaked at $283K in Q2 2015. 62 funds tracked by Wall St. Rank hold BDSI as of Q3 2017.

Buckingham Strategic Wealth reported no remaining BioDelivery Sciences International, Inc. position as of Q3 2017 after selling out during the quarter.
Buckingham Strategic Wealth sold 35,600 BioDelivery Sciences International, Inc. shares in Q3 2017, an estimated $100K.
Buckingham Strategic Wealth first reported a position in BioDelivery Sciences International, Inc. in Q2 2015 and held it in 9 quarters.
Buckingham Strategic Wealth's BioDelivery Sciences International, Inc. position peaked at $283K in Q2 2015.
62 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q3 2017.

Based on Buckingham Strategic Wealth's 13F filing for Q3 2017, filed 8 Nov 2017.